25 June 2020 : Clinical Research
Serum Amyloid A: A Potential Biomarker Assessing Disease Activity in Systemic Lupus Erythematosus
Cai-Mei Wang1EFG, Jin-Huan Deng1EFG, Guo-Fei Mao1B, Yong-Ling He1B, Xiang Shi1AC*DOI: 10.12659/MSM.923290
Med Sci Monit 2020; 26:e923290
Figure 1 Serum amyloid A (SAA) in patients with active systemic lupus erythematosus (SLE) and patients with inactive SLE. P<0.001, Mann-Whitney U test.






